Sollievo Fiziolax is a 100% natural medical device indicated in the treatment of constipation.
The action of the product is obtained thanks to the totality of the natural substances present, which act on the numerous functions normally performed by the intestine to regulate transit; Sollievo Fiziolax therefore acts through a physiological and non-pharmacological mechanism of action;
Physiological laxative action:
propulsive effect on intestinal transit.
protective effect on the intestinal mucosa.
increased intestinal motility.
increased hydration of fecal matter.
increased protection of the mucosa on the intestinal wall.
modulation of inflammation.
this representation of the physiological mechanism of action is the result of our molecular and cellular biology studies in combination with bioinformatics processing.
Ingredients: Sollievo Fiziolax Complex (obtained from Senna, Chicory, Fennel, Dandelion, Cumin and Caraway) 420 mg/tablet; 100% natural and biodegradable; Complex of polyphenols with flavonoids and sennosides>= 3.1%.
Does not contain synthetic, semi-synthetic or genetically modified substances
How to use: It is recommended to consume 1 to 3 tablets in the evening, as needed, with a large glass of water. The correct dosage is the minimum sufficient to favor a physiological intestinal transit that does not produce liquid feces, therefore it can be adapted to individual needs. The product is recommended from the age of 12.
Recommendations: In general, to favor intestinal transit, it is recommended to consume liquids throughout the day, consume a correct amount of fiber and perform physical activity.
Precautions: Do not use in case of hypersensitivity or individual allergy to one or more components of the product. Do not exceed the maximum recommended dose. Keep out of reach and sight of small children. In case of persistent constipation, it is important to consult a doctor. Store at room temperature, in a cool, dry place and away from light.
Presentation form: 45 + 27 tablets


Reviews
There are no reviews yet.